Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs
Sarah Larney, Jason Grebely, Matthew Hickman, Daniela De Angelis, Gregory J Dore, Louisa Degenhardt
International Journal of Drug Policy | ELSEVIER SCIENCE BV | Published : 2015
Awarded by NHMRC
Awarded by Medical Research Council
Awarded by National Institute for Health Research
Thank you to James Jansson, Maryam Salehi Alavi and David Wilson for assistance in the development of this paper. SL is supported by an NHMRC Early Career Fellowship (no. 1035149). JG is supported by an NHMRC Career Development Fellowship (no. 1035383). GJD is supported by NHMRC Practitioner Research Fellowship (no. 1028432). LD is supported by an NHMRC Principal Research Fellowship (no. 1041742). The National Drug and Alcohol Research Centre at the University of NSW is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australia Government. No funding body had any role in study design, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the article for publication.